Results 221 to 230 of about 101,002 (279)

Compact bone-derived mesenchymal stem cells attenuate nonalcoholic steatohepatitis in a mouse model by modulation of CD4 cells differentiation

, 2016
Huafeng Wang, Dong Wang, Luhong Yang, Yanxia Wang, Junli Jia, Dongchen Na, Huize Chen, Yongping Luo, Chengfang Liu   +8 more
openalex   +1 more source

Correction: Exploring the mechanisms of tetrahydrocurcumin in ameliorating nonalcoholic steatohepatitis based on network pharmacology and gut microbiota analysis <i>in vivo</i> and <i>in vitro</i>. [PDF]

Front Microbiol
Chen K, Wang J, Luo S, Quan Y, Wei P, Fu J, Ma J, Yang Y, Liu Y, Gao Z.   +9 more
europepmc   +1 more source

Effects of 12 Weeks of Exercise on Hepatic TNF-α and PPARα in an Animal Model of High-Fat Diet-Induced Nonalcoholic Steatohepatitis

, 2009
Haifeng Zhang, Yuxiu He, Pak‐Kwong Chung, Tom K. Tong, Frank H. Fu, Yujuan Chen, Guangfa Jiao   +6 more
openalex   +1 more source

Taking hypoglycemic drugs may affect the association between ferritin and nonalcoholic steatohepatitis. [PDF]

Rev Assoc Med Bras (1992)
Hu R, Zeng LH.
europepmc   +1 more source

Questionnaire survey on lifestyle of patients with nonalcoholic steatohepatitis

, 2014
Haruka Noto, Katsutoshi Tokushige, Etsuko Hashimoto, Makiko Taniai, Keiko Shiratori   +4 more
openalex   +2 more sources

Prevalence and Correlates of Probable Nonalcoholic Steatohepatitis (NASH) in Pars Cohort Study. [PDF]

Arch Iran Med
Nakhostin-Ansari A, Menbari Oskouie I, Aghajani R, Khadembashiri MM, Ahmadi M, Gandomkar A, Malekzadeh F, Poustchi H, Fattahi MR, Anushiravani A, Malekzadeh R.   +10 more
europepmc   +1 more source

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status

, 2009
Lance L. Stein, Mamie H. Dong, Rohit Loomba   +2 more
openalex   +2 more sources

Necroptosis in Nonalcoholic Steatohepatitis

Cellular and Molecular Gastroenterology and Hepatology, 2015
Jérémie Gautheron, PhD, Mihael Vucur, PhD, Tom Luedde MD,, PhD   +2 more
doaj   +1 more source

Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. [PDF]

World J Hepatol
Shan GY, Wan H, Zhang YX, Cheng JY, Qiao DR, Liu YY, Shi WN, Li HJ.   +7 more
europepmc   +1 more source

Oligonucleotide therapies for nonalcoholic steatohepatitis. [PDF]

Mol Ther Nucleic Acids
Li S, Xiong F, Zhang S, Liu J, Gao G, Xie J, Wang Y.   +6 more
europepmc   +1 more source